Literature DB >> 32656058

Microbial spectrum, antibiotic susceptibility profile, and biofilm formation of diabetic foot infections (2014-18): a retrospective multicenter analysis.

Fakhria A Al-Joufi1, Khalid M Aljarallah2,3, Soheir A Hagras4,5, Ibrahim M Al Hosiny6, Mounir M Salem-Bekhit7, Abdullah M E Youssof7, Faiyaz Shakeel7.   

Abstract

This study identifies the risk factors, microbiological properties, antimicrobial susceptibility patterns, mortality, and clinical complications associated with organisms causing diabetic foot infections (DFIs) with or without antibiotic treatment using data from a retrospective multicenter surveillance. Specimens collected from different hospitals were cultured and the extended-spectrum β-lactamase (ESBL) excretion was estimated. The antibacterial susceptibility pattern and biofilm formation were completed along with the recommended standard methods. Overall, 792 diabetic foot patients (DFPs) were enrolled and a total of 1803 causative organisms were isolated. Polymicrobial infection was identified in 48.5% of the patients. The isolated Gram-positive pathogens (46.7%) were higher than Gram-negative (38.6%) or anaerobes (7.9%). The predominant pathogens were S. aureus (22.2%), methicillin-resistant S. aureus (7.7%), Enterococcus spp. (12.8%), Pseudomonas aeruginosa (9.4%), E. coli (7.9%), Klebsiella spp. (7.5%), Proteus mirabilis (8.9%), coagulase negative staphylococci (CoNS) (6.6%), anaerobic organisms (5.9%), and fungi (2.3%). Vancomycin and clindamycin exhibited no activity against Gram-positive bacteria. However, meropenem and imipenem displayed high activity against the Gram-negative isolates. Out of the 765 tested strains, 251 showed moderate (15.8%) to high (34%) level biofilm-producing phenotype. DFIs were widespread among the diabetic patients with different microbial etiology and the major organisms were aerobic organisms. Our findings may provide an insight into the development of appropriate therapeutic strategies for the management of DFIs. © King Abdulaziz City for Science and Technology 2020.

Entities:  

Keywords:  Diabetic foot infections; Enterococci; Methicillin-resistant S. aureus; β-lactamase

Year:  2020        PMID: 32656058      PMCID: PMC7326867          DOI: 10.1007/s13205-020-02318-x

Source DB:  PubMed          Journal:  3 Biotech        ISSN: 2190-5738            Impact factor:   2.406


  27 in total

1.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.

Authors:  H Pham; D G Armstrong; C Harvey; L B Harkless; J M Giurini; A Veves
Journal:  Diabetes Care       Date:  2000-05       Impact factor: 19.112

2.  Biofilms in chronic wounds.

Authors:  Garth A James; Ellen Swogger; Randall Wolcott; Elinor deLancey Pulcini; Patrick Secor; Jennifer Sestrich; John W Costerton; Philip S Stewart
Journal:  Wound Repair Regen       Date:  2007-12-13       Impact factor: 3.617

Review 3.  16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls.

Authors:  J Michael Janda; Sharon L Abbott
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

4.  Inpatient management of diabetic foot problems: summary of NICE guidance.

Authors:  T Tan; E J Shaw; F Siddiqui; P Kandaswamy; P W Barry; M Baker
Journal:  BMJ       Date:  2011-03-23

5.  Evaluation of different methods for detecting methicillin (oxacillin) resistance in Staphylococcus aureus.

Authors:  David Velasco; Maria del Mar Tomas; Monica Cartelle; Alejandro Beceiro; Astrid Perez; Francisca Molina; Rita Moure; Rosa Villanueva; German Bou
Journal:  J Antimicrob Chemother       Date:  2005-02-18       Impact factor: 5.790

6.  Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study.

Authors:  Asima Banu; Mir Mohammad Noorul Hassan; Janani Rajkumar; Sathyabheemarao Srinivasa
Journal:  Australas Med J       Date:  2015-09-30

7.  Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods.

Authors:  T Mathur; S Singhal; S Khan; D J Upadhyay; T Fatma; A Rattan
Journal:  Indian J Med Microbiol       Date:  2006-01       Impact factor: 0.985

8.  Contrasting effects of acidic pH on the extracellular and intracellular activities of the anti-gram-positive fluoroquinolones moxifloxacin and delafloxacin against Staphylococcus aureus.

Authors:  Sandrine Lemaire; Paul M Tulkens; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

9.  Bacterial etiology of diabetic foot infections in South India.

Authors:  E M Shankar; V Mohan; G Premalatha; R S Srinivasan; A R Usha
Journal:  Eur J Intern Med       Date:  2005-12       Impact factor: 4.487

10.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

View more
  1 in total

1.  Bacteriological profile and antibiotic susceptibility of diabetic Foot infections at Ribat University hospital; a retrospective study from Sudan.

Authors:  Maram H Hamid; Ahmed H Arbab; Bashir A Yousef
Journal:  J Diabetes Metab Disord       Date:  2020-10-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.